Rejected
at 8:11 p.m. Jan, 03, 2025 ]
by
Cameron
Author:
zarathustra
Type of change:
Other
Rationale for change
formatting
Rejection reason
Not necessary to emphasize, more a fun fact
Current
Suggested
Extra
Extra
Extra
Extra
Text
Daclizumab is a monoclonal antibody against {{c1::CD25 (part of IL-2 receptor)}} that was previously used to treat {{c2::relapsing multiple sclerosis}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid


Sketchy
Empty field
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize



Review IL-2



Review IL-2
Physeo
Empty field
OME
Additional Resources
Empty field
One by one
Empty field
